Kappler K - Search Results

1

Randomized placebo-controlled clinical trial of high-dose interleukin-2 in combination with a soluble p75 tumor necrosis factor receptor immunoglobulin G chimera in patients with advanced melanoma and renal cell carcinoma.

Du Bois JS, Trehu EG, Mier JW, Shapiro L, Epstein M, Klempner M, Dinarello C, Kappler K, Ronayne L, Rand W, Atkins MB. Du Bois JS, et al. Among authors: kappler k. J Clin Oncol. 1997 Mar;15(3):1052-62. doi: 10.1200/JCO.1997.15.3.1052. J Clin Oncol. 1997. PMID: 9060545 Clinical Trial.

2

Phase I evaluation of thrice-daily intravenous bolus interleukin-4 in patients with refractory malignancy.

Atkins MB, Vachino G, Tilg HJ, Karp DD, Robert NJ, Kappler K, Mier JW. Atkins MB, et al. Among authors: kappler k. J Clin Oncol. 1992 Nov;10(11):1802-9. doi: 10.1200/JCO.1992.10.11.1802. J Clin Oncol. 1992. PMID: 1403061 Clinical Trial.

3

Interleukin-6-associated anemia: determination of the underlying mechanism.

Atkins MB, Kappler K, Mier JW, Isaacs RE, Berkman EM. Atkins MB, et al. Among authors: kappler k. Blood. 1995 Aug 15;86(4):1288-91. Blood. 1995. PMID: 7632934 Free article. Clinical Trial.

4

Multiinstitutional phase II trial of intensive combination chemoimmunotherapy for metastatic melanoma.

Atkins MB, O'Boyle KR, Sosman JA, Weiss GR, Margolin KA, Ernest ML, Kappler K, Mier JW, Sparano JA, Fisher RI, et al. Atkins MB, et al. Among authors: kappler k. J Clin Oncol. 1994 Aug;12(8):1553-60. doi: 10.1200/JCO.1994.12.8.1553. J Clin Oncol. 1994. PMID: 8040667 Clinical Trial.

5

A two-part phase I trial of high-dose interleukin 2 in combination with soluble (Chinese hamster ovary) interleukin 1 receptor.

McDermott DF, Trehu EG, Mier JW, Sorce D, Rand W, Ronayne L, Kappler K, Clancy M, Klempner M, Atkins MB. McDermott DF, et al. Among authors: kappler k. Clin Cancer Res. 1998 May;4(5):1203-13. Clin Cancer Res. 1998. PMID: 9607578 Clinical Trial.

6

Phase I trial of interleukin 2 in combination with the soluble tumor necrosis factor receptor p75 IgG chimera.

Trehu EG, Mier JW, Dubois JS, Sorce D, Klempner MS, Epstein M, Dinarello CA, Shapiro L, Kappler K, Ronayne L, Atkins MB. Trehu EG, et al. Among authors: kappler k. Clin Cancer Res. 1996 Aug;2(8):1341-51. Clin Cancer Res. 1996. PMID: 9816306 Clinical Trial.

7

Evaluation of the Efficacy and Safety of Blue Fenugreek Kale Extract on Skin Health and Aging: In-vitro and Clinical Evidences.

Kappler K, Grothe T, Srivastava S, Jagtap M. Kappler K, et al. Clin Cosmet Investig Dermatol. 2022 Sep 28;15:2051-2064. doi: 10.2147/CCID.S368576. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 36199383 Free PMC article.

8

A Quality Initiative to Decrease Time Until Analgesic for Fracture-associated Pain in the Pediatric Emergency Department.

Davis J, Kappler K, Stoker S. Davis J, et al. Among authors: kappler k. Pediatr Qual Saf. 2021 Sep 24;6(5):e469. doi: 10.1097/pq9.0000000000000469. eCollection 2021 Sep-Oct. Pediatr Qual Saf. 2021. PMID: 34589643 Free PMC article.

9

Limited Neonatal Carbohydrate-Specific Antibody Repertoire Consecutive to Partial Prenatal Transfer of Maternal Antibodies.

Kappler K, Restin T, Lasanajak Y, Smith DF, Bassler D, Hennet T. Kappler K, et al. Front Immunol. 2020 Oct 14;11:573629. doi: 10.3389/fimmu.2020.573629. eCollection 2020. Front Immunol. 2020. PMID: 33162988 Free PMC article.

10

Increased Antibody Response to Fucosylated Oligosaccharides and Fucose-Carrying Bacteroides Species in Crohn's Disease.

Kappler K, Lasanajak Y, Smith DF, Opitz L, Hennet T. Kappler K, et al. Front Microbiol. 2020 Jul 14;11:1553. doi: 10.3389/fmicb.2020.01553. eCollection 2020. Front Microbiol. 2020. PMID: 32765449 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters